Authors

• O. Odenike
• W Stock
• M Tallarico
• Michael W. Drazer (ORCID: https://orcid.org/0000-0002-8171-4106)
• Sinan Cem Cetin
• Mariam T. Nawas (ORCID: https://orcid.org/0000-0001-5161-0878)
• Michael J. Thirman (ORCID: https://orcid.org/0000-0001-5154-9499)
• Anand Patel (ORCID: https://orcid.org/0000-0002-0296-8686)
• Gregory W. Roloff (ORCID: https://orcid.org/0000-0003-2109-5152)
• Muriel R. Battaglia (ORCID: https://orcid.org/0000-0002-0292-7884)
• Adam DuVall (ORCID: https://orcid.org/0000-0002-9163-8792)
• Joseph Cannova
• Melissa Yuwono Tjota (ORCID: https://orcid.org/0000-0002-5869-3175)
• Jeremy Segal
• Bayard L. Powell
• Girish Venkataraman
• Peng Wang

Institutions

• Cancer Treatment Centers of America (US)
• University of Chicago (US)

Publication Details

Journal

Haematologica

Published

2026-01-29

DOI

https://doi.org/10.3324/haematol.2025.288518

Primary Topic

PARP inhibition in cancer therapy

Type

article

Field-Weighted Citation Impact

0.00